Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
04/17/2025 06:25 PM - Politics
Lai calls for more trade cooperation with NZ amid global challenges
04/17/2025 06:17 PM - Science & Tech
Taiwan doctors help develop 90% accurate Alzheimer's blood test
04/17/2025 05:45 PM - Business
U.S. tariffs could cut Taiwan manufacturing production by 5%: NDC
04/17/2025 05:23 PM - Business
TSMC leaves 2025 sales forecast unchanged despite Trump's tariffs
04/17/2025 04:45 PM